Ketamine for Depression—Knowns, Unknowns, Possibilities, Barriers, and Opportunities

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms

(2023) Adam Włodarczyk et al.   Pharmaceuticals

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

(2023) Amit Anand et al.   NEW ENGLAND JOURNAL OF MEDICINE

The efficacy of oral ketamine in severely depressed patients at high risk of suicide

(2023) Saswinder Kaur et al.   Asian Journal of Psychiatry

Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode

(2022) Taeho Greg Rhee et al.   JAMA Psychiatry

Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT)

(2021) Joakim Ekstrand et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

(2021) Zach Walsh et al.   BJPsych Open

A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019

(2020) Walter S. Marcantoni et al.   JOURNAL OF AFFECTIVE DISORDERS

The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis

(2020) Jiaqi Xiong et al.   JOURNAL OF PSYCHIATRIC RESEARCH